Despite a Q1 revenue miss due to currency headwinds, core EPS beat expectations for AstraZeneca. Read why AZN stock is a Buy.

Richard Childress Racing in the NASCAR Cup Series at the Chicago Street Race… NASCAR returns to Chicago for the sport’s only street race, which weaves through Chicago’s Grant Park area, artfully ...

One of the most popular gaming YouTubers is named Bloo, but he isn’t a human — he’s a fully virtual personality powered by ...

See the latest AstraZeneca PLC ADR stock price (AZN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar ...

A new blood test uses what is known as biomarkers to identify a person’s Alzheimer’s disease status, changing how we monitor ...

AstraZeneca has teamed up with DNA sequencing giant Illumina on a new programme that will use artificial intelligence to find new targets for drug discovery by sifting through vast arrays of data ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

Feast your eyes on the 2024 Audi RS7 Performance in stunning Ascari Blue Matte. Combining aggressive styling, a powerful twin ...

Review quarterly and annual revenue, net income, and cash flow for AstraZeneca PLC ADR (AZN:XNAS) stock through the last fiscal year.